期刊文献+

结直肠癌肝转移患者预后列线图模型实证研究 被引量:1

Empirical study of the prognostic nomogram model in patients with liver metastasis of colorectal cancer
原文传递
导出
摘要 目的 通过建立列线图生存预测模型,探讨影响结直肠癌肝转移患者的相关因素,更好的为结直肠癌肝转移患者的个性化治疗及预后判断提供指导依据。方法 回顾性分析2010-01-01-2019-12-31就诊于新疆医科大学附属肿瘤医院的1 131例同时性结直肠癌肝转移患者。使用Cox比例风险回归确定患者的独立预后因素。通过R软件采用随机抽样法将患者按照7∶3的比例分为建模组(792例)和验证组(339例),构建列线图预测总生存期,并绘制受试者工作特征(ROC)曲线和校准曲线进行验证。结果 年龄>60岁(HR=0.65,95%CI:0.46~0.91)、临床分期Ⅳ期(HR=0.66,95%CI:0.45~0.96),N分期N2b期(HR=2.54,95%CI:1.16~5.55)、淋巴结转移率(LNR)>0.6(HR=1.63,95%CI:0.95~2.78)和微卫星高度不稳定状态(HR=0.39,95%CI:0.14~1.09)为结直肠癌肝转移患者预后的独立危险因素,均P<0.1。纳入独立危险因素构建患者1、3和5年生存率列线图。建模组1、3和5年生存率ROC值分别为0.621、0.612和0.587;验证组分别为0.602、0.657和0.596。总生存期的校准曲线相对接近理想45°参考线,表明模型的预测值与实际值吻合良好,模型具有良好的临床有效性。结论 本研究构建的列线图模型具有较好的预测效果,有利于临床实践中为患者制定针对性、个性化的治疗方案,提高患者有效生存率。 Objective By establishing a column chart survival prediction model,this study explores the relevant factors affecting patients with liver metastasis from colorectal cancer,and provided better guidance for personalized treatment and prognosis judgment of patients with liver metastasis from colorectal cancer.Methods Retrospective analysis was conducted on 1131patients with simultaneous liver metastasis and colorectal cancer who were admitted in Xinjiang Cancer Center from January 1,2010to December 31,2019.Cox proportional risk regression was used to determine independent prognostic factors for patients.R software and random sampling method were used to divide patients into a modeling group(792cases)and a validation group(339cases)in a 7∶3ratio.A nomographic chart was constructed to predict overall survival,and receiver operating characteristic(ROC)curves and calibration curves were plotted for validation.Results Age>60years old(HR=0.65,95%CI:0.46-0.91),clinical stageⅣ(HR=0.66,95%CI:0.45-0.96),N_(2b)stage(HR=2.54,95%CI:1.16-5.55),lymph node metastasis rate(LNR)>0.6(HR=1.63,95%CI:0.95-2.78),and highly unstable microsatellite status(HR=0.39,95%CI:0.14-1.09)were independent risk factors for the prognosis of colorectal cancer patients with liver metastasis,all P<0.1.Independent risk factors were included to construct patients'1-year,3-year,and 5-year survival nomograms.The ROC values of overall survival for modeling groups at1,3,and 5years were 0.621,0.612and 0.587,respectively;Those in the validation groups were 0.602,0.657and0.596,respectively.The calibration curve of the overall survival was relatively close to the ideal 45°reference line,indicating that the predicted values of the model were in good agreement with the actual values,and the model has good clinical effectiveness.Conclusion The column chart model constructed in this study has good predictive performance,which is conducive to developing targeted and personalized treatment plans for patients in clinical practice and improving their effective survival rate.
作者 陈晨 罗冬梅 葛磊 顾晓芬 CHEN Chen;LUO Dongmei;GE lei;GU Xiaofen(School of Public Health,Xinjiang Medical University,Urumqi,Xinjiang 830011,China;Affiliated Cancer Hospital of Xinjiang Medical University,Urumqi,Xinjiang 83001l,China;Department of Gastrointestinal Surgery,Affiliated Hospital of Guangdong Medical University,Zhanjiang,Guangdong 524002,China)
出处 《中华肿瘤防治杂志》 CAS 北大核心 2023年第22期1362-1368,共7页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然科学基金地区科学基金(81960434) 新疆维吾尔自治区自然科学基金(2022D01C296) 全国多中心中晚期结直肠癌患者诊疗现状及医务人员认知现况调查研究(20200101)。
关键词 结直肠癌 肝转移 生存分析 预后 列线图模型 colorectal cancer liver metastasis survival analysis prognosis nomogram model
  • 相关文献

参考文献5

二级参考文献106

  • 1林怡,陶丽.结直肠癌转移的中医理论构想[J].上海中医药杂志,2020,54(2):6-9. 被引量:13
  • 2包满都拉,苏昊,罗寿,徐正,明光,梁建伟,刘正,刘骞,周志祥,王锡山,周海涛.结直肠癌肝转移手术和新辅助化疗策略[J].肝癌电子杂志,2020(1):45-50. 被引量:5
  • 3Ferlay J SI, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M,Parkin DM, Forman D, Bray, F. GLOBOCAN 2012 v1.0, CancerIncidence and Mortality Worldwide: IARC CancerBase No. 11[Internet]. Lyon, France: International Agency for Research onCancer, 2013.
  • 4Jung KW, Park S, Kong HJ, Won YJ, Lee JY, Seo HG, Lee JS.Cancer statistics in Korea: incidence, mortality, survival, andprevalence in 2009. Cancer Res Treat 2012; 44: 11-24 [PMID:22500156 DOI: 10.4143/crt.2012.44.1.11].
  • 5Matsuda A, Matsuda T, Shibata A, Katanoda K, Sobue T,Nishimoto H. Cancer incidence and incidence rates in Japan in2008: a study of 25 population-based cancer registries for theMonitoring of Cancer Incidence in Japan (MCIJ) project. Jpn JClin Oncol 2014; 44: 388-396 [PMID: 24503029 DOI: 10.1093/jjco/hyu003].
  • 6Hansen IO, Jess P. Possible better long-term survival in left versusright-sided colon cancer - a systematic review. Dan Med J 2012;59: A4444 [PMID: 22677242].
  • 7Pal SK, Hurria A. Impact of age, sex, and comorbidity on cancertherapy and disease progression. J Clin Oncol 2010; 28: 4086-4093[PMID: 20644100 DOI: 10.1200/jco.2009.27.0579].
  • 8Kaku E, Oda Y, Murakami Y, Goto H, Tanaka T, Hasuda K,Yasunaga M, Ito K, Sakurai K, Fujimori T, Hattori M, Sasaki Y.Proportion of flat- and depressed-type and laterally spreadingtumor among advanced colorectal neoplasia. Clin GastroenterolHepatol 2011; 9: 503-508 [PMID: 21440090 DOI: 10.1016/j.cgh.2011.03.018].
  • 9Saunders BP, Fukumoto M, Halligan S, Jobling C, Moussa ME,Bartram CI, Williams CB. Why is colonoscopy more difficult inwomen- Gastrointest Endosc 1996; 43: 124-126 [PMID: 8635705].
  • 10Brenner H, Haug U, Hundt S. Sex differences in performanceof fecal occult blood testing. Am J Gastroenterol 2010; 105:2457-2464 [PMID: 20700114 DOI: 10.1038/ajg.2010.301].

共引文献85

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部